Tag:

Qiagen

Latest Headlines

Latest Headlines

Qiagen to pony up $100M+ for Danish molecular diagnostics outfit Exiqon

Diagnostics giant Qiagen will make a bid to acquire Vedbaek, Denmark-based Exiqon for about 683 million Danish kroner ($103.5 million), the company announced Tuesday. The Danish company specializes in molecular diagnostics and life science research tools.

10X Genomics strikes deals with Illumina, Agilent and Qiagen

10X Genomics has entered into collaborations with Illumina, Agilent Technologies and Qiagen. The long-read specialist, which emerged from stealth mode last year with a $55.5 million fundraising round, has struck the deals to boost the reach and capabilities of products based on its GemCode technology.

Dx Digest: Illumina inks four genetic research deals; Trovagene makes moves in liquid biopsy with additional coverage for tests

In this week's Dx Digest, Illumina inked four biobanking deals to spur genetic research, liquid biopsy player Trovagene nabbed a coverage agreement for its cancer diagnostics, and diagnostics heavyweight Qiagen joined forces with genomics firm CosmosID to launch a metagenomics and microbiome analysis tool.

Genomic Health readies for liquid biopsy test launch; Foundation Medicine jumps on liquid biopsy bandwagon amid positive Q4 numbers

In this week's Dx Digest, Genomic Health announced plans to roll out its liquid biopsy test in 2016. Foundation Medicine revealed positive Q4 numbers and talked up its liquid biopsy ambitions. And Qiagen expanded its companion diagnostics prowess through a deal with Array BioPharma.

Qiagen backs liquid biopsy startup Exosome in $60M Series B

Diagnostics giant Qiagen has joined the syndicate of Exosome Diagnostics--helping to distinguish this liquid biopsy startup from its growing crowd of peers. The pair are already partnered under a 2014 lung cancer diagnostic development deal. The Cambridge, MA-based startup has raised a $60 million Series B round to launch its liquid biopsy test via its CLIA-certified lab as well as to seek out companion diagnostics deals with biopharmas.

Qiagen scores FDA approval for lung cancer companion Dx

Qiagen snagged FDA approval for its test for AstraZeneca's lung cancer drug, building on its previous relationship with the biotech titan to claim more ground in the companion diagnostics field.

Qiagen scores FDA approval for lung cancer companion Dx

Qiagen snagged FDA approval for its test for AstraZeneca's lung cancer drug, building on its previous relationship with the biotech titan to claim more ground in the companion diagnostics field.

Qiagen launches Germany-based JV aimed at companion Dx

Qiagen relies on companion diagnostics to keep its engine running, and the company is looking to gain some ground in the field through a new joint venture with German molecular diagnostics outfit Biotype Diagnostic.

Qiagen launches Germany-based JV aimed at companion Dx

Qiagen relies on companion diagnostics to keep its engine running, and the company is looking to gain some ground in the field through a new joint venture with German molecular diagnostics outfit Biotype Diagnostic.

Qiagen to partner with Japan's Hitachi on molecular testing

Qiagen will combine its expertise in assays and biomarker panels with Hitachi's knowledge of instrumentation and manufacturing to advance research-based and clinical molecular testing via a strategic collaboration.